AI assistant
Sending…
ORASURE TECHNOLOGIES INC — Director's Dealing 2017
Aug 9, 2017
33573_dirs_2017-08-09_83a84569-601d-4049-901c-a774c4db3c5e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORASURE TECHNOLOGIES INC (OSUR)
CIK: 0001116463
Period of Report: 2017-08-07
Reporting Person: Zezzo II Anthony (EVP - Infectious Diseases)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-08-07 | Common stock | M | 72916 | $5.7149 | Acquired | 218326 | Direct |
| 2017-08-07 | Common stock | S | 72916 | $21.2614 | Disposed | 145410 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-08-07 | Nonqualified stock options | $5.7149 | M | 72916 | Disposed | 2024-02-03 | Common stock (72916) | Direct |
Footnotes
F1: Nonqualified stock options granted on February 3, 2014 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.
More from ORASURE TECHNOLOGIES INC
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 17
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Major Shareholding Notification
2026
Mar 18
Regulatory Filings
2026
Mar 17
Proxy Solicitation & Information Statement
2026
Mar 17
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 25